Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Finished Goods (2016 - 2025)

Standard Biotools (LAB) has disclosed Finished Goods for 15 consecutive years, with $12.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Finished Goods rose 39.62% to $12.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $12.7 million, a 39.62% increase, with the full-year FY2024 number at $7.3 million, down 10.49% from a year prior.
  • Finished Goods was $12.7 million for Q3 2025 at Standard Biotools, down from $13.9 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $15.2 million in Q4 2022 to a low of $7.3 million in Q4 2024.
  • A 5-year average of $11.1 million and a median of $11.0 million in 2021 define the central range for Finished Goods.
  • Peak YoY movement for Finished Goods: surged 60.21% in 2021, then crashed 46.8% in 2023.
  • Standard Biotools' Finished Goods stood at $10.6 million in 2021, then skyrocketed by 43.64% to $15.2 million in 2022, then plummeted by 46.8% to $8.1 million in 2023, then dropped by 10.49% to $7.3 million in 2024, then soared by 74.66% to $12.7 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Finished Goods are $12.7 million (Q3 2025), $13.9 million (Q2 2025), and $11.6 million (Q1 2025).